Ignite Creation Date:
2024-05-06 @ 3:17 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02257424
Status:
COMPLETED
Last Update Posted:
2022-01-20
First Post:
2014-10-02
Brief Title:
Dabrafenib Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
Sponsor:
Organization:
Abramson Cancer Center at Penn Medicine